Financhill
Sell
44

BRLT Quote, Financials, Valuation and Earnings

Last price:
$2.00
Seasonality move :
-18.84%
Day range:
$1.95 - $2.01
52-week range:
$1.52 - $3.81
Dividend yield:
0%
P/E ratio:
66.83x
P/S ratio:
0.36x
P/B ratio:
1.89x
Volume:
48.9K
Avg. volume:
83.1K
1-year change:
-41.37%
Market cap:
$27.3M
Revenue:
$446.4M
EPS (TTM):
$0.03
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $201.3M $251.8M $380.2M $439.9M $446.4M
Revenue Growth (YoY) -- 25.07% 50.98% 15.7% 1.48%
 
Cost of Revenues $116.4M $139.5M $192.8M $205.6M $189.4M
Gross Profit $84.9M $112.3M $187.4M $234.3M $257M
Gross Profit Margin 42.18% 44.6% 49.3% 53.26% 57.57%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $90.3M $85.7M $147.3M $211M $252.5M
Other Inc / (Exp) -$126K -$74K -$6.6M $188K $4.9M
Operating Expenses $90.3M $85.7M $147.3M $211M $252.5M
Operating Income -$5.4M $26.6M $40.1M $23.3M $4.5M
 
Net Interest Expenses $2.3M $4.9M $7.6M $4.7M $5.1M
EBT. Incl. Unusual Items -$7.8M $21.6M $25.9M $18.9M $4.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -$316K -$168K -$431K
Net Income to Company -$7.8M $21.6M $26.3M $19M $4.7M
 
Minority Interest in Earnings -- -- -$24.7M -$16.9M -$4.2M
Net Income to Common Excl Extra Items -$7.8M $21.6M $1.5M $2.1M $584K
 
Basic EPS (Cont. Ops) -$0.93 $2.59 $0.16 $0.20 $0.05
Diluted EPS (Cont. Ops) -$0.93 $2.59 $0.10 $0.15 $0.04
Weighted Average Basic Share $8.3M $8.3M $9.6M $10.7M $11.9M
Weighted Average Diluted Share $8.3M $8.3M $96.7M $96.5M $97.1M
 
EBITDA -$4.9M $27.2M $34.4M $25.4M $13.6M
EBIT -$5.5M $26.5M $33.5M $23.5M $9.4M
 
Revenue (Reported) $201.3M $251.8M $380.2M $439.9M $446.4M
Operating Income (Reported) -$5.4M $26.6M $40.1M $23.3M $4.5M
Operating Income (Adjusted) -$5.5M $26.5M $33.5M $23.5M $9.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $71.4M $95.2M $111.4M $114.2M $99.9M
Revenue Growth (YoY) -- 33.3% 16.97% 2.47% -12.51%
 
Cost of Revenues $40.6M $47.2M $50.5M $47.3M $39.1M
Gross Profit $30.8M $48M $60.9M $66.8M $60.8M
Gross Profit Margin 43.18% 50.42% 54.68% 58.54% 60.85%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $21.5M $38.1M $54.6M $64.8M $61.8M
Other Inc / (Exp) -$59K -$4M $374K $1.4M $1.5M
Operating Expenses $21.5M $38.1M $54.6M $64.8M $61.8M
Operating Income $9.3M $9.9M $6.3M $2M -$1.1M
 
Net Interest Expenses $1.2M $1.9M $778K $1.3M $1.3M
EBT. Incl. Unusual Items $8M $4M $5.9M $2.1M -$864K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $23K $180K $95K $211K
Net Income to Company -- $4M $5.7M $2M -$1.1M
 
Minority Interest in Earnings -- -$3.9M -$5.1M -$1.8M $934K
Net Income to Common Excl Extra Items $8M $66K $646K $245K -$141K
 
Basic EPS (Cont. Ops) $0.96 $0.01 $0.06 $0.02 -$0.01
Diluted EPS (Cont. Ops) $0.96 $0.01 $0.05 $0.02 -$0.01
Weighted Average Basic Share $8.3M $9.6M $10.9M $12.1M $13.5M
Weighted Average Diluted Share $8.3M $96.6M $96.6M $97.2M $13.5M
 
EBITDA $9.4M $6.1M $7.2M $4.5M $1.8M
EBIT $9.3M $5.9M $6.7M $3.4M $456K
 
Revenue (Reported) $71.4M $95.2M $111.4M $114.2M $99.9M
Operating Income (Reported) $9.3M $9.9M $6.3M $2M -$1.1M
Operating Income (Adjusted) $9.3M $5.9M $6.7M $3.4M $456K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- $346.9M $442.2M $441.7M $427M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- $180.1M $211M $192.2M $170.8M
Gross Profit -- $166.8M $231.1M $249.4M $256.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- $124.9M $200.9M $240.1M $254M
Other Inc / (Exp) -$59K -$6.5M -$434K $4M $6M
Operating Expenses -- $124.9M $200.9M $240.1M $254M
Operating Income -- $41.9M $30.2M $9.3M $2.1M
 
Net Interest Expenses $1.2M $7.1M $5.5M $4.8M $5.1M
EBT. Incl. Unusual Items -- $28.2M $24.3M $8.5M $3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $23K $50K -$438K -$328K
Net Income to Company -- -- $24.2M $9M $3.3M
 
Minority Interest in Earnings -- -$3.9M -$21.4M -$7.9M -$2.9M
Net Income to Common Excl Extra Items -- $24.3M $2.9M $1.1M $426K
 
Basic EPS (Cont. Ops) -- $2.41 $0.29 $0.10 $0.03
Diluted EPS (Cont. Ops) -- $2.41 $0.20 $0.05 $0.03
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- $36M $31.4M $17M $13.2M
EBIT -- $35.3M $29.8M $13.3M $8.1M
 
Revenue (Reported) -- $346.9M $442.2M $441.7M $427M
Operating Income (Reported) -- $41.9M $30.2M $9.3M $2.1M
Operating Income (Adjusted) -- $35.3M $29.8M $13.3M $8.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $71.4M $258.3M $320.3M $322M $302.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $40.6M $133.1M $151.4M $138M $119.5M
Gross Profit $30.8M $125.1M $168.9M $184M $183.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $21.5M $98M $151.6M $180.7M $182.2M
Other Inc / (Exp) -$59K -$6.5M -$351K $3.4M $4.5M
Operating Expenses $21.5M $98M $151.6M $180.7M $182.2M
Operating Income $9.3M $27.2M $17.3M $3.3M $940K
 
Net Interest Expenses $1.2M $5.8M $3.7M $3.8M $3.8M
EBT. Incl. Unusual Items $8M $14.9M $13.2M $2.9M $1.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- $23K $389K $119K $222K
Net Income to Company -- $14.8M $12.8M $2.8M $1.4M
 
Minority Interest in Earnings -- -$3.9M -$11.4M -$2.5M -$1.2M
Net Income to Common Excl Extra Items $8M $11M $1.4M $341K $183K
 
Basic EPS (Cont. Ops) $0.96 $0.81 $0.14 $0.03 $0.01
Diluted EPS (Cont. Ops) $0.96 $0.81 $0.11 $0.00 $0.01
Weighted Average Basic Share $8.3M $34.6M $31.7M $35.3M $39.5M
Weighted Average Diluted Share $8.3M $121.6M $289.3M $205.5M $209.6M
 
EBITDA $9.4M $21.2M $18.2M $9.7M $9.3M
EBIT $9.3M $20.7M $16.9M $6.7M $5.4M
 
Revenue (Reported) $71.4M $258.3M $320.3M $322M $302.6M
Operating Income (Reported) $9.3M $27.2M $17.3M $3.3M $940K
Operating Income (Adjusted) $9.3M $20.7M $16.9M $6.7M $5.4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $40.4M $66.3M $172.9M $154.6M $155.8M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory $10.8M $13.6M $24.7M $39.3M $37.8M
Prepaid Expenses -- -- -- -- --
Other Current Assets $2.3M $2.9M $8.2M $11.8M $11M
Total Current Assets $53.7M $83M $206M $205.9M $204.9M
 
Property Plant And Equipment $2M $2M $6.7M $44.4M $56.3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $252K $258K $601K $3.3M $2.7M
Total Assets $55.9M $85.2M $217.7M $262.6M $273.6M
 
Accounts Payable $10.8M $10.8M $14.5M $11M $4.5M
Accrued Expenses $7.3M $10.8M $19M $28.5M $31.3M
Current Portion Of Long-Term Debt -- -- $30.8M $3.3M $4.1M
Current Portion Of Capital Lease Obligations -- -- -- $3.9M $5M
Other Current Liabilities $2.2M $1.3M $3.2M $2.8M $6M
Total Current Liabilities $32M $38.7M $92.8M $74.5M $76.9M
 
Long-Term Debt $32.7M $62.2M $32.8M $59.5M $55.6M
Capital Leases -- -- -- -- --
Total Liabilities $147.4M $170.6M $134.9M $169.4M $176.1M
 
Common Stock -$91.5M -$85.4M $10K $10K $10K
Other Common Equity Adj -- -- -- -- --
Common Equity -$91.5M -$85.4M $8.4M $10.9M $12.5M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $74.4M $82.2M $84.9M
Total Equity -$91.5M -$85.4M $82.8M $93.1M $97.5M
 
Total Liabilities and Equity $55.9M $85.2M $217.7M $262.6M $273.6M
Cash and Short Terms $40.4M $66.3M $172.9M $154.6M $155.8M
Total Debt $32.7M $62.2M $63.6M $62.7M $59.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- $161.1M $152.9M $147.1M $152.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- $20.1M $40.3M $37.3M $38.5M
Prepaid Expenses -- -- -- -- --
Other Current Assets -- $7.7M $9.8M $11.3M $11.3M
Total Current Assets -- $189M $203.2M $195.9M $202.7M
 
Property Plant And Equipment -- $6M $37.4M $57.9M $57.8M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- $552K $3.1M $2.7M $3.4M
Total Assets -- $199.9M $252.4M $265.7M $273.2M
 
Accounts Payable -- $11.5M $10.4M $4.1M $2.2M
Accrued Expenses -- $19M $27.6M $26.9M $26.6M
Current Portion Of Long-Term Debt -- $20.5M $3.3M $3.7M $6.5M
Current Portion Of Capital Lease Obligations -- -- $3.3M $4.9M $5.9M
Other Current Liabilities -- $2.5M $5.2M $3.9M $5.6M
Total Current Liabilities -- $78.6M $77.6M $70.8M $72.4M
 
Long-Term Debt -- $42.7M $60.2M $56.7M $51.6M
Capital Leases -- -- -- -- --
Total Liabilities -- $130M $167.8M $172.2M $168.9M
 
Common Stock -- $10K $10K $10K $10K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- $62.9M $74.9M $81.6M $89.9M
Total Equity -- $70M $84.6M $93.4M $104.4M
 
Total Liabilities and Equity -- $199.9M $252.4M $265.7M $273.2M
Cash and Short Terms -- $161.1M $152.9M $147.1M $152.7M
Total Debt -- $63.2M $63.5M $60.4M $58.1M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$7.8M $21.6M $26.3M $19M $4.7M
Depreciation & Amoritzation $622K $646K $860K $1.9M $4.2M
Stock-Based Compensation $43K $46K $2.8M $8.8M $10M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$2.4M -$2.8M -$11.2M -$14.8M $1.5M
Cash From Operations $567K $26.7M $46.1M $14.5M $26.2M
 
Capital Expenditures $678K $584K $5.6M $9.1M $11.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$678K -$584K -$5.6M -$9.1M -$11.9M
 
Dividends Paid (Ex Special Dividend) -- -$30M -- -- --
Special Dividend Paid
Long-Term Debt Issued $35M $32.7M -- $65M --
Long-Term Debt Repaid -$11M -$2.7M -- -$69M -$3.3M
Repurchase of Common Stock -- -- -$14M -- --
Other Financing Activities -$1.4M -$263K -$21.4M -$19.6M -$9.9M
Cash From Financing $22.6M -$263K $66.1M -$23.6M -$13.1M
 
Beginning Cash (CF) $18.1M $40.6M $66.5M $173.1M $154.9M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $22.5M $25.9M $106.6M -$18.2M $1.2M
Ending Cash (CF) $40.6M $66.5M $173.1M $154.9M $156M
 
Levered Free Cash Flow -$111K $26.1M $40.5M $5.4M $14.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $4M $5.7M $2M -$1.1M
Depreciation & Amoritzation -- $215K $501K $1.1M $1.3M
Stock-Based Compensation -- $684K $2.3M $2.6M $2.5M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -$2.9M -$5.1M $2.2M -$314K
Cash From Operations -- $13.6M $4.1M $4.6M $2M
 
Capital Expenditures -- $1.7M $2.5M $1.6M $1.3M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$1.7M -$2.5M -$1.6M -$1.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$813K -$813K --
Repurchase of Common Stock -- -$14M -- -- -$179K
Other Financing Activities -- -$3.6M -$3.4M -$4.7M -$50K
Cash From Financing -- $84.2M -$4.3M -$5.5M -$229K
 
Beginning Cash (CF) -- $65.2M $155.7M $149.8M $152.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $96.1M -$2.6M -$2.5M $445K
Ending Cash (CF) -- $161.3M $153.1M $147.3M $152.9M
 
Levered Free Cash Flow -- $11.9M $1.6M $3.1M $674K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- $24.2M $9M $3.3M
Depreciation & Amoritzation -- -- $1.6M $3.7M $5.1M
Stock-Based Compensation -- $872K $8.5M $9.7M $10M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -$20.3M $2.9M -$1.1M
Cash From Operations -- -- $21.3M $21M $14.2M
 
Capital Expenditures -- $4.4M $7.8M $13.3M $3.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$7.8M -$13.3M -$3.9M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -$68.2M -$3.3M -$2.4M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -$18.1M -$10.3M -$1.9M
Cash From Financing -- -- -$21.6M -$13.5M -$4.7M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -$8.2M -$5.8M $5.5M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- $13.5M $7.7M $10.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- $14.8M $12.8M $2.8M $1.4M
Depreciation & Amoritzation -- $536K $1.2M $3M $3.8M
Stock-Based Compensation -- $872K $6.6M $7.5M $7.5M
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -$6.5M -$15.6M $2M -$585K
Cash From Operations -- $33.8M $9M $15.5M $3.5M
 
Capital Expenditures -- $4.4M $6.6M $10.7M $2.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$4.4M -$6.6M -$10.7M -$2.7M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- $65M -- --
Long-Term Debt Repaid -- -- -$68.2M -$2.4M -$1.6M
Repurchase of Common Stock -- -$14M -- -- -$438K
Other Financing Activities -- -$22.5M -$19.2M -$9.9M -$1.9M
Cash From Financing -- $65.4M -$22.4M -$12.3M -$3.9M
 
Beginning Cash (CF) -- $204.4M $493.9M $450.8M $456.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- $94.8M -$19.9M -$7.5M -$3.2M
Ending Cash (CF) -- $299.2M $474M $443.3M $453M
 
Levered Free Cash Flow -- $29.4M $2.5M $4.8M $774K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock